Category Archives: M&A Activity
MHA Acquired by Roper Industries
Managed Health Care Associates, Inc. (“MHA”), a diversified health care services and technology company focused on alternate site providers has been acquired by Roper Industries. MHA provides expertise in Group Purchasing, Managed Care and Payer Contracting, Reimbursement Management, Specialty Pharmacy Solutions, Pharmaceutical Data Analytics, Clinical Pharmacy Software and Legislative Advocacy. Roper Industries is also a well-diversified company and is a constituent of the S&P 500, Fortune 1000, and the Russell 1000 indices. Among other things, Roper provides engineered products and solutions for global niche markets, including software information networks, medical, water, energy, and transportation. Going forward, the MHA will be [...]
[More...]
Comments (0)
Big Pharma Preparing for a Pipeline Shopping Spree, Says GlobalData
Despite a recent fall in deal volume and overall value, some of the pharmaceutical industry’s major players are about to splash out in an effort to restock depleted drug pipelines, says an analyst with research and consulting firm GlobalData. In a new report, Adam Dion, analyst with GlobalData, states that industry leaders such as Pfizer, Merck, GSK and AstraZeneca are paying the price for failing to adequately prepare for the effects of the patent cliff. This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry [...]
[More...] Comments (0)
MedAssets Partners with SAP/Ariba –The eCommerce Competitive Landscape Just Changed
MedAssets, Inc. (NASDAQ: MDAS) today announced a multi-year strategic partnership with Ariba (recently purchased by SAP) that significantly expands MedAssets’ industry-leading supply chain management and outsourced procurement capabilities. The goal of the partnership is to offer healthcare providers and suppliers the industry’s most comprehensive electronic commerce platform, including requisition to purchase order (PO) transmission, shipment notification, invoice transmission and reconciliation workflow automation, expense posting, supplier payment and early-pay discount solutions. More from the Press Release: Through this partnership, healthcare providers will be able to conduct fully automated e-commerce with the nearly one million companies connected to the Ariba® Network through [...]
[More...] Comments (0)
The Medical Innovation Playbook –Heard of it?
A little more than 80% of all providers in the U.S. are non-profits. However, 100% of the largest and most successful ones also have well-established for-profit business interests. Whether through arms length arrangements or wholly owned and integrated business entities, the largest IDNs have restructured, renamed and realigned themselves to take ever-increasing advantage of their for-profit side, as success in this realm provides a wonderful type of insurance coverage –a nice “balance.” According to its website, “the Medical Innovation Playbook details the diverse and rapidly evolving technology commercialization programs of America’s top medical centers. It is the first comprehensive effort [...]
[More...] Comments (0)
Allscripts Buys dbMotion and Jardogs –An ACO Service Strategy Revealed
Yesterday, Paul Black, Allscripts’ new CEO announced two deals: Allscripts acquired privately held health solutions providers, dbMotion, Ltd. and Jardogs LLC. The dbMotion solution has some significant IP associated with it, supporting what is known as “semantic interoperability.” At the application level, it aggregates and harmonizes clinical content into a single clinical view, clarifying disparate codes and vocabularies used inside EHRs. In doing so, it forms a foundation for accountable care and population health management. The Jardogs FollowMyHealth solution enables “patient engagement,” allowing patients to actively monitor and optimize health status by participating in their own care, which is critical [...]
[More...] Comments (0)
This Year’s HIMSS Discussion Priorities –Ovum’s 2013 Take
This coming week, Ovum, an information and communication technologies (ICT) specialized research and consulting firm, will be at the HIMSS conference in New Orleans. Bill Clinton is speaking, as a major activity of the Clinton Foundation is fighting childhood obesity. “Treating and preventing obesity-related diseases requires a profound shift to patient-centric care,” says Charlotte Davies, lead analyst of Ovum’s Healthcare practice. “This is a major strategic shift, and it has become the guiding force of the HIMSS’ agenda. Achieving this requires action across the board; a much more strategic approach to IT and service design, changes in legislation; addressing the [...]
[More...] Comments (0)
Cardinal To Acquire AssuraMed, Direct-To-Home Distributor for $2.07B
Late last week, Cardinal Health announced plans to acquire privately held AssuraMed, another Ohio-based healthcare concern and leading provider of medical supplies to chronically ill patients in the home. The price? $2.07 billion. The acquisition will be financed with a combination of $1.3 billion in new senior unsecured notes and the remainder in cash. The deal is expected to close by early April this year. “AssuraMed is a natural extension of the Cardinal Health businesses and of our mission to be essential to care. The acquisition of this industry leader allows us to serve the growing number of Americans treated in [...]
[More...] Comments (0)
Cleveland Clinic/VHA Joint Venture Will Be Transformative
The Cleveland Clinic, a long time member of Premier, has left the roost. It has entered into a joint venture with VHA that the parties are saying, “will transform the traditional group purchasing approach into a strategic sourcing model.” The joint venture has been structured as a LLC. It is being organized to knock the lid off PPI costs –with a particular emphasis on implantables. The idea isn’t new. For example, SharedClarity is the result of a partnership that brought together UnitedHealthcare, Dignity Health, and 11 additional health systems. More than just aggregating demand to more competitively source PPI, they [...]
[More...] Comments (0)
2013: Five Top Healthcare Trends –An Entrepreneur’s Take
Healthcare Matters would like to welcome the following guest post from Melissa Thompson, CEO of Talk Session, an online counseling platform that will soon connect users with professionals for on-demand, mobile therapy. Melissa offers her opinions on five trends that will dominate the healthcare front in 2013. We know where the analysts stand, so let’s consider an entrepreneur’s take. Despite the regulatory difficulties, 2013 will surely be an exciting year for healthcare. We will see an increase in self-management and collaboration. We will see an influx of innovation in mainstream health-related consumer products, data will be more readily available, and [...]
[More...] Comments (0)
Blues: Seeking Answers to Difficult Questions
Healthcare Matters would like to welcome the following guest post from David McCament, ISG’s Healthcare Vertical and Information Services Group Director. ISG is a research, consulting and managed service firm. In today’s dynamic healthcare environment, the regional Blues face uncertainty and a slew of difficult business challenges. First off, many still lag significantly in terms of operational efficiency and lack even basic levels of process and sourcing maturity. Many others face the additional task of rationalizing myriad administrative systems. And among those who recognize the issues, many do not have the institutional knowledge or experience to make the appropriate changes [...]
[More...] Comments (0)
Apple Shares Dip Below $500… Time to Buy?
Apple shares fell as low as $483.80 during this morning’s session, with the stock trading at $484.10, a decline of $17.65, or 3.5 percent. For the second consecutive day, Apple faces the prospect of closing lower than $500. The company has been in a freefall since introducing the iPhone 5. Although Apple hit an all-time high of $705.07 the day the iPhone 5 launched, it’s been nothing but a long slide downward since then –down 28.8 percent through Monday’s session. The latest news that the company has cut back on component orders for the iPhone 5 is said to be [...]
[More...] Comments (0)
Baxter Acquires Gambro AB –Renal Supply Markets Further Consolidate
Baxter International announced today that it would buy privately held Swedish dialysis product company Gambro AB for about $4 billion ($2.8 billion in cash plus debt) to complement its kidney therapy portfolio. Baxter will finance the deal, which it valued at $26.5 billion Swedish kroner. Baxter reported cash reserves of $3.2 billion as of Sept. 30, and posted a $2.2 billion profit last year on revenue of $13.9 billion, so its pockets are plenty deep. The Gambro acquisition will round out Baxter’s renal business, which accounted for almost one-fifth of the company’s 2011 revenue of $13.89 billion. Gambro was founded [...]
[More...] Comments (0)
The “Fiscal Cliff” and Healthcare: GHX CEO Makes Industry Predictions
The healthcare market remains a precarious place to do business, said GHX CEO Bruce Johnson. “What’s at risk,” said Johnson, “is the entire healthcare system, which spans not only traditional care organizations in the U.S., but also the huge U.S. base of global manufacturers.” According to a June 2012 report from the Congressional Budget Office (CBO), when combining the current rate of healthcare cost increases with similarly substantial increases in healthcare demand (aging population), the debt burdens are unsustainable. “The choice for healthcare is dig in or embrace change,” said Johnson. “With the impending changes to healthcare resulting from the [...]
[More...] Comments (0)
Blue Cross Blue Shield “Circling the Wagons” –Seeking Finality to ObamaCare’s New Regulations
Do they consolidate even further or lobby for changes that serve their independence? That’s what the “Blues” are asking themselves these days and, of course, the answer is, “both.” Providing health insurance for almost one third of all Americans, the nation’s Blue Cross and Blue Shield (BCBS) plans are poised for a new wave of consolidation. And while they’re at it, they’re lobbying hard to influence what the final implementation of the health law is going to look like. Call it a little extra insurance. Sarah Cliff of the Washington Post reported that the Blues have been arguing for more [...]
[More...] Comments (0)
SAP & Molecular Health to Shape Personalized Medicine (PMx) Market
The concept of personalized medicine (PMx) is less than 20 years old, and it does not have a perfect track record. But where it has been proven successful, it has been a game-changer –for providers, payors and especially patients, who can finally participate, meaningfully, in their own care. When physicians and patients can efficiently integrate genetic and biological data into the diagnostic process, personalized therapy will become the norm –there will be no turning back. Yesterday, SAP AG (NYSE: SAP) and MolecularHealth, a leader in clinico-molecular informatics™, announced that they have joined forces to create a clinical decision-making system designed [...]
[More...] Comments (0)
P/E Ratios in Healthcare: Can You Trust Them?
In terms of P/E ratios, what follows are the top five in the Health Care Technology sector. Keep in mind, a higher P/E ratio means that investors are paying more for each unit of net income, so by definition, the stock is more expensive compared to companies with lower P/E ratios. But what does it really mean? Although the analysts will warn you to not compare P/E ratios between companies that aren’t in the same industry, all of the companies listed below while being in the same industry are not at all in the same line of work. MedAssets, the [...]
[More...] Comments (1)
- Healthcare in the Cloud: Forecast Still Hazy : HIMSS 2013: Top Takeaways Gathering Clouds said: [...] to David McCament’s mind, the future of healthcare cloud is not so clear. In a gue... more
- Time Definite Logistics –MNX Expands Global Network and Adds Track & Trace : Daniel said: Everything is very open with a precise description of the issues. It was definitely inform... more
- Varian Runs a “Clinic” in Effective Lobbying –Harry Reid Rides Shotgun : Thomas Finn said: Thanks for your comment Bo. I do not fully comprehend the differences between the two opti... more
- Varian Runs a “Clinic” in Effective Lobbying –Harry Reid Rides Shotgun : Barton 'Bo' Cooke said: Tom, you nailed it. This rider, put in at the last minute and was rushed into the Congres... more
Spend Matters Compass research is based on a year-long editorial calendar, exploring bigger picture areas and issues
Next Level Sourcing and Commodity Management
New Paper P2P and Working Capital
Services Procurement Innovation
ERP Procurement and Spend Management Applications
Spend Matters Perspectives research is focused on targeted topics that impact specific areas in procurement
